TrialBritish journal of haematology2014

Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.

Steven E Coutre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.